Docquity, Southeast Asia's largest community of healthcare professionals (HCPs), and global biopharmaceutical leader AstraZeneca developed OAZisCare, an end-to-end patient support program (PSP) that improves cancer care and enhanced Respiratory Syncytial Virus (RSV) vaccine education and adherence in Thailand.

Docquity，东南亚最大的医疗保健专业人员（HCP）社区，与全球生物制药领导者阿斯利康共同开发了OAZisCare，这是一个端到端的患者支持计划（PSP），旨在改善泰国的癌症护理，并加强呼吸道合胞病毒（RSV）疫苗的教育和依从性。

Developed in 2024 as a digital support program for patients and caregivers, OAZisCare has provided learning resources to tens of thousands in just a year, registering eligible patients into its adherence program..

2024年开发的患者和护理人员数字支持项目OAZisCare仅在一年内就为数万人提供了学习资源，并将其符合条件的患者注册到其依从性计划中。

OAZisCare is powered by DocquityCare, the patient solutions arm of Docquity, delivering secure, data-driven omnichannel solutions to improve patient education, adherence, and affordability for major healthcare challenges in Southeast Asia. The program is managed by Docquity's team of HCPs, educators, content creators, and technology developers, equipped with specialized resources and knowledge to engage and support critical illness patients as well as their caregivers..

OAZisCare 由 Docquity 的患者解决方案部门 DocquityCare 提供支持，致力于为东南亚地区的主要医疗挑战提供安全、数据驱动的全渠道解决方案，以改善患者的教育、依从性和可负担性。该计划由 Docquity 的医疗保健专业人员（HCP）、教育工作者、内容创作者和技术开发人员团队管理，配备了专门的资源和知识，能够有效吸引并支持重症患者及其护理人员。

The OAZisCare website and initiative's social media outreach provide a range of valuable educational materials—including articles, podcasts, and videos—to enable more holistic care for cancer patients. It also facilitated RSV vaccine awareness amid a seasonal increase of RSV in Thailand1, especially for children.

OAZisCare网站和该倡议的社交媒体推广提供了一系列有价值的教育资源——包括文章、播客和视频——以促进对癌症患者的更全面护理。此外，它还在泰国RSV季节性高发期间促进了RSV疫苗的认知度，特别是针对儿童。

OAZisCare also follows up with eligible patients for enrolment in an adherence program, seamlessly increasing access to the healthcare they need..

OAZisCare 还会跟进符合条件的患者，让他们加入依从性计划，无缝增加他们获得所需医疗服务的机会。

Addressing Southeast Asia's Vaccine Gap

解决东南亚的疫苗缺口问题

OAZisCare's RSV vaccine patient support in Thailand is an example of how Docquity responds to the region's healthcare challenges, such as vaccine needs. A recent Docquity Pulse Check survey of over 700 Southeast Asian doctors found that 85.4% have at least one patient who could benefit from vaccines, and 85.7% believe vaccine rates could improve with PSPs.

OAZisCare的RSV疫苗患者支持在泰国是Docquity应对该地区医疗挑战（如疫苗需求）的一个例子。最近，Docquity对700多名东南亚医生进行的Pulse Check调查显示，85.4%的医生至少有一名患者能从疫苗中受益，85.7%的医生认为通过患者支持计划（PSPs）可以提高疫苗接种率。

However, only 46.1% have a patient managed by a PSP2. .

然而，只有46.1%的患者由PSP2管理。

The study also revealed that 83.9% of doctors view 'low patient awareness on vaccine benefits' as the main barrier to better vaccination rates, emphasizing greater patient education, adherence, and affordability as key regional priorities.

该研究还显示，83.9% 的医生认为“患者对疫苗益处的认识不足”是提高接种率的主要障碍，强调加强患者教育、依从性和可负担性是关键的区域优先事项。

'Digital advancements empower us to democratize patient knowledge on essential treatments and improve access to them like never before. Through DocquityCare, we are utilizing our proprietary industry insights and platform technologies to expand patient support for pressing healthcare issues such as cancer care, rare diseases, vaccine preventable diseases, and low adherence medications, in pursuit of building healthier lives across Southeast Asia and beyond,' said Christophe Meugnier, CCO and General Manager of Vietnam & Thailand at Docquity..

“数字技术的进步使我们能够普及患者对必要治疗的认识，并以前所未有的方式改善他们获取治疗的机会。通过DocquityCare，我们正在利用自身独有的行业洞察和平台技术，扩大对癌症治疗、罕见病、疫苗可预防疾病以及低依从性药物等紧迫医疗问题的患者支持，致力于改善东南亚及更广泛地区的健康生活。” Docquity首席商务官兼越南和泰国总经理Christophe Meugnier表示。

Since its successful pilot in the Philippines in 2022, DocquityCare has grown to support 18 programs across the region.

自 2022 年在菲律宾成功试点以来，DocquityCare 已发展到支持该地区的 18 个项目。

For more information about OAZisCare, please visit the official website or follow the OAZisCare official LINE account.

有关 OAZisCare 的更多信息，请访问官方网站或关注 OAZisCare 官方 LINE 账号。

About Docquity

关于Docquity

Docquity is Southeast Asia's largest community of verified healthcare professionals (HCPs). Our platform and services leverage data science to strengthen healthcare knowledge and interactions.

Docquity 是东南亚最大的经验证的医疗保健专业人员 (HCP) 社区。我们的平台和服务利用数据科学来加强医疗保健知识和互动。

The Docquity vision is to connect HCPs to build healthier lives around the world at scale. Our platform helps HCPs learn, connect, and grow, while our deep network insights enable healthcare enterprises to understand, engage, and educate HCPs.

Docquity的愿景是连接医疗保健专业人员（HCP），以大规模改善全球健康生活。我们的平台帮助HCP学习、交流和成长，同时我们深入的网络洞察使医疗保健企业能够理解、吸引并教育HCP。

We are trusted by more than 410,000 HCPs across Southeast Asia, with offices in India, Indonesia, Malaysia, the Philippines, Singapore, Taiwan, Thailand, and Vietnam.

我们受到东南亚超过410,000名医疗保健专业人士的信任，并在印度、印度尼西亚、马来西亚、菲律宾、新加坡、台湾、泰国和越南设有办事处。

Docquity is available for download on Apple and Android devices.

Docquity 可在苹果和安卓设备上下载。

Source: prnewswire.com

来源：prnewswire.com